To include your compound in the COVID-19 Resource Center, submit it here.

Xarelto rivaroxaban regulatory update

Bayer submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for Xarelto rivaroxaban

Read the full 166 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE